NSE · BSE · Real-time
High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.
Promoters of Novelix Pharmaceuticals have increased their equity stake by acquiring 3,37,500 shares through the conversion of warrants. The transaction, valued at ₹6.75 crore, was conducted on a preferential allotment basis across four promoter entities.
Real-time NSE & BSE event alerts, AI-summarized filings, and instant order-win signals — free for 15 days, no card required.
